No it wasn't. The 2 abstains count as "no's" so the decision is a 7-6 like I had predicted. So in a case like this it is almost solely up to the FDA to decide and guess what FDA will focus on confirmatory trials because of the size of the trials are too small currently. So I am issuing my recommendation which is a CRL for an additional trial.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.